Click here for Analysts' Upgrades, Downgrades.
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
(ABC - Get Report)
added to Conviction Buy List at Goldman. Company has good earnings visibility over the next couple of years.
(AGCO - Get Report)
estimates, target upped at Goldman. AGCO estimates were boosted through 2012. Visibility is improving for demand in Western Europe. Buy rating and new $55 price target.
(ALGT - Get Report)
price target cut at Barclays to $59 from $61. Investing in ALGT is risky, outlook uncertain, Barclays said. Maintain Overweight rating.
target, estimates higher at Credit Suisse. AMAT price target raised by a dollar to $15. Strong sector view, Credit Suisse said. 2010 and 2011 EPS estimates raised to $0.87 and $1.25, respectively. Maintain Neutral rating.
(DRI - Get Report)
target boosted at Oppenheimer to $57. Company is likely seeing higher sales, especially at Red Lobster.
(EW - Get Report)
price target higher at Barclays to $80 from $75. Building out commercial infrastructure ahead of the potentially significant Sapien launch, Barclays said. Maintain Overweight rating.
Health Management Associates
price target boosted at Barclays by a dollar to $11. HMA has shown continued signs of progress with better-than-expected revenue growth, Barclays said. Maintain Overweight rating.
US Airways Group
price target raised at Barclays by a dollar to $15. Supply and demand balance in the industry will improve in the coming years, Barclays said. Maintain Equal Weight rating.
target, estimate boosted at Barclays to $43 from $35 on stronger growth, Credit Suisse said. 2011 and 2012 EPS estimates increased to $3.56 and $3.69, respectively. Maintain Outperform rating.
target increased at Oppenheimer. OXY target was raised to $105, Oppenheimer said. Company recently boosted its dividend and should continue to generate steady cash flow.
target raised at Oppenheimer. Shares of PXD now seen reaching $96, according to Oppenheimer. Company can continue to outperform its peers, despite lower energy prices.
price target raised at Barclays. TSO price target increased to $20 from $16 after positive meeting with management, Barclays said. Maintain Equal Weight rating.